Skip to content
Search

Latest Stories

Scottish pharmacies to hold Naloxone in national bid to reduce overdose deaths

The Naloxone Scheme was rolled out through community pharmacies on 30 October

Scottish community pharmacies will now hold two Naloxone kits, available in either nasal spray or injectable form, essential for reversing opioid overdoses.


The Emergency Access Naloxone Scheme, which is backed by £300,000 of Scottish Government funding, began on Monday.

Drugs and Alcohol Policy Minister Elena Whitham said, “Through our National Mission to reduce drug deaths and harms, we have invested more than £3 million in widening access to Naloxone, including through our emergency services.”

"This new nationwide service is a welcome addition to existing services. Police Scotland recently completed a force-wide rollout to 12,500 officers who have used the kits more than 300 times.

According to the most recent statistics, 70 per cent of those who are at risk of opioid overdose are being provided with a lifesaving kit,” she added.

“It provides a substantial increase in life-saving emergency access and I’m grateful to all those in community pharmacies who are supporting our £250 million National Mission to reduce drug deaths,” Whitham said.

The PMR suppliers affirmed that pharmacy IT software will enable pharmacy teams to provide naloxone emergency supply from the launch date.

The community pharmacy contractors must ensure that their pharmacy teams complete the e-learning module for naloxone emergency supply, available on the NES TURAS Learn website.

Community Pharmacy Scotland incoming CEO Matt Barclay said, “CPS is pleased to have community pharmacy participating in delivering this key role to support a reduction in drug deaths across Scotland.

“It once again sees community pharmacy at the heart of the community, delivering care for the citizens of Scotland,” he added.

In a July 2022 report, the Drug Death Taskforce suggested that all community pharmacies should have naloxone available for emergency use.

They should also be capable of providing take-home naloxone (THN) to individuals who use drugs, their families, and anyone likely to witness an opioid overdose.

A Scottish Government NHS circular also indicated that a Take Home Naloxone (THN) service through pharmacies will follow later.

Moreover, a new universal claim framework (UCF) module will be accessible for claims when naloxone kits are dispensed or expire.

Meanwhile, Scotland’s drug death rate remains the highest in Europe, despite National Records of Scotland statistics in August indicating drug deaths in 2022 had fallen to their lowest since 2017, to 1,051.

The following month Scottish government figures indicated suspected drug deaths rose in the first six months of 2023, with 600 such fatalities between January to June – 7 per cent higher than the same time in 2022.

In August, the UK Home Affairs Committee urged the government to overhaul its existing drug policy, shifting from a strictly 'abstinence only' approach to a more pragmatic strategy that emphasises harm reduction.

The committee's suggestions also included the implementation of a national naloxone program in England, where community pharmacies would play a pivotal role in enabling access.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less